Detailed Information on Publication Record
2024
A perspective on genetic and polygenic risk scores - advances and limitations and overview of associated tools
SCHWARZEROVÁ, Jana, Martin HURTA, Vojtěch BARTOŇ, Matej LEXA, Dirk WALTHER et. al.Basic information
Original name
A perspective on genetic and polygenic risk scores - advances and limitations and overview of associated tools
Authors
SCHWARZEROVÁ, Jana (203 Czech Republic, guarantor), Martin HURTA (203 Czech Republic), Vojtěch BARTOŇ (203 Czech Republic, belonging to the institution), Matej LEXA (703 Slovakia, belonging to the institution), Dirk WALTHER (276 Germany), Valentine PROVAZNÍK (203 Czech Republic, belonging to the institution) and Wolfram WECKWERTH (40 Austria)
Edition
Briefings in Bioinformatics, OXFORD, Oxford University Press, 2024, 1467-5463
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10201 Computer sciences, information science, bioinformatics
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 9.500 in 2022
Organization unit
Faculty of Medicine
UT WoS
001273456200003
Keywords in English
polygenic risk score; genetic variations; GWAS; genomic prediction; genotype; phenotype
Tags
International impact, Reviewed
Změněno: 12/9/2024 09:47, Mgr. Tereza Miškechová
Abstract
V originále
Polygenetic Risk Scores are used to evaluate an individual's vulnerability to developing specific diseases or conditions based on their genetic composition, by taking into account numerous genetic variations. This article provides an overview of the concept of Polygenic Risk Scores (PRS). We elucidate the historical advancements of PRS, their advantages and shortcomings in comparison with other predictive methods, and discuss their conceptual limitations in light of the complexity of biological systems. Furthermore, we provide a survey of published tools for computing PRS and associated resources. The various tools and software packages are categorized based on their technical utility for users or prospective developers. Understanding the array of available tools and their limitations is crucial for accurately assessing and predicting disease risks, facilitating early interventions, and guiding personalized healthcare decisions. Additionally, we also identify potential new avenues for future bioinformatic analyzes and advancements related to PRS.